Ark Invest Sells $7.4 Million Worth of BioNTech Shares

Cathie Wood's Ark Genomic Revolution ETF sold over 122,000 shares of BioNTech for approximately $7.4 million in early July 2026, reducing its stake to just 307 shares valued at around $28,000. The move suggests a strategic shift as the fund reallocates capital amid underperformance and financial challenges faced by BioNTech.

By Jack Delaney, The Motley Fool Tue, July 14, 2026 at 5:02 PM GMT+3 3 min read · Yahoo Finance · July 14, 2026, 14:02 UTC

Tickers: $ARKG $BNTX

Topics: Ark Invest ARKG ETF BioNTech stock sales

Read the full article at Yahoo Finance

More World news

EnterpriseDB Hires CMRD Engineering Team to Strengthen Sovereign AI Governance PR Newswire · November 12, 2026, 18:36 UTC
Alliant Credit Union Executive Meredith Ritchie Named 2027 Chicago Titan 100 Honoree PR Newswire · November 12, 2026, 18:36 UTC
Fed's Schmid Argues Construction Productivity is Key to Housing Affordability Over Interest Rate Cuts Seeking Alpha · November 12, 2026, 18:33 UTC
PROG Holdings Reports 59% GMV Growth and Announces $100 Million Share Repurchase Program Motley Fool · November 12, 2026, 18:30 UTC
Corteva Shares Plunge Over Q3 Earnings Miss and Pricing Pressures Motley Fool · November 12, 2026, 18:31 UTC
Teekay Tankers Shares Decline Despite Q3 Earnings Beat and New Vessel Orders Seeking Alpha · November 12, 2026, 18:27 UTC
U.S. 30-Year Treasury Auction Yields Rise as Demand Weakens Seeking Alpha · November 12, 2026, 18:30 UTC
Nvidia Names Colette Kress Interim CEO Following Jensen Huang's Resignation Motley Fool · November 12, 2026, 18:26 UTC
Bit Digital Reports Q3 2026 Net Income of $28.5 Million Amid Revenue Decline Motley Fool · November 12, 2026, 18:26 UTC
EZCORP Reports Strong Q4 2026 Results with Significant EBITDA and Revenue Growth Motley Fool · November 12, 2026, 18:16 UTC